161 related articles for article (PubMed ID: 11119421)
21. Effects of inflammatory response on in vivo transgene expression by plasmid DNA in mice.
Kako K; Nishikawa M; Yoshida H; Takakura Y
J Pharm Sci; 2008 Aug; 97(8):3074-83. PubMed ID: 18064709
[TBL] [Abstract][Full Text] [Related]
22. Cationic liposome-mediated gene delivery to the liver and to hepatocellular carcinomas in mice.
Mohr L; Yoon SK; Eastman SJ; Chu Q; Scheule RK; Scaglioni PP; Geissler M; Heintges T; Blum HE; Wands JR
Hum Gene Ther; 2001 May; 12(7):799-809. PubMed ID: 11339896
[TBL] [Abstract][Full Text] [Related]
23. Transfection efficiency and toxicity following delivery of naked plasmid DNA and cationic lipid-DNA complexes to ovine lung segments.
Emerson M; Renwick L; Tate S; Rhind S; Milne E; Painter HA; Boyd AC; McLachlan G; Griesenbach U; Cheng SH; Gill DR; Hyde SC; Baker A; Alton EW; Porteous DJ; Collie DD
Mol Ther; 2003 Oct; 8(4):646-53. PubMed ID: 14529838
[TBL] [Abstract][Full Text] [Related]
24. DNA vector augments inflammation in epithelial cells via EGFR-dependent regulation of TLR4 and TLR2.
Liu K; Anderson GP; Bozinovski S
Am J Respir Cell Mol Biol; 2008 Sep; 39(3):305-11. PubMed ID: 18403779
[TBL] [Abstract][Full Text] [Related]
25. Plasmid DNA activates murine macrophages to induce inflammatory cytokines in a CpG motif-independent manner by complex formation with cationic liposomes.
Yasuda K; Ogawa Y; Kishimoto M; Takagi T; Hashida M; Takakura Y
Biochem Biophys Res Commun; 2002 Apr; 293(1):344-8. PubMed ID: 12054606
[TBL] [Abstract][Full Text] [Related]
26. Efficient Packaging of Plasmid DNA Using a pH Sensitive Cationic Lipid for Delivery to Hepatocytes.
Sakurai Y; Matsuda T; Hada T; Harashima H
Biol Pharm Bull; 2015; 38(8):1185-91. PubMed ID: 26235581
[TBL] [Abstract][Full Text] [Related]
27. Increased duration of transgene expression in the lung with plasmid DNA vectors harboring adenovirus E4 open reading frame 3.
Yew NS; Marshall J; Przybylska M; Wysokenski DM; Ziegler RJ; Rafter PW; Li C; Armentano D; Cheng SH
Hum Gene Ther; 1999 Jul; 10(11):1833-43. PubMed ID: 10446923
[TBL] [Abstract][Full Text] [Related]
28. Non-immunostimulatory nonviral vectors.
Liu F; Shollenberger LM; Huang L
FASEB J; 2004 Nov; 18(14):1779-81. PubMed ID: 15364893
[TBL] [Abstract][Full Text] [Related]
29. A concentrated and stable aerosol formulation of cationic lipid:DNA complexes giving high-level gene expression in mouse lung.
Eastman SJ; Lukason MJ; Tousignant JD; Murray H; Lane MD; St George JA; Akita GY; Cherry M; Cheng SH; Scheule RK
Hum Gene Ther; 1997 Apr; 8(6):765-73. PubMed ID: 9113516
[TBL] [Abstract][Full Text] [Related]
30. Studies of direct intratumoral gene transfer using cationic lipid-complexed plasmid DNA.
Clark PR; Stopeck AT; Ferrari M; Parker SE; Hersh EM
Cancer Gene Ther; 2000 Jun; 7(6):853-60. PubMed ID: 10880015
[TBL] [Abstract][Full Text] [Related]
31. Cancer gene therapy using plasmid DNA: safety evaluation in rodents and non-human primates.
Parker SE; Vahlsing HL; Serfilippi LM; Franklin CL; Doh SG; Gromkowski SH; Lew D; Manthorpe M; Norman J
Hum Gene Ther; 1995 May; 6(5):575-90. PubMed ID: 7578395
[TBL] [Abstract][Full Text] [Related]
32. Binding and uptake of cationic lipid:pDNA complexes by polarized airway epithelial cells.
Chu Q; Tousignant JD; Fang S; Jiang C; Chen LH; Cheng SH; Scheule RK; Eastman SJ
Hum Gene Ther; 1999 Jan; 10(1):25-36. PubMed ID: 10022528
[TBL] [Abstract][Full Text] [Related]
33. Mechanistically probing lipid-siRNA nanoparticle-associated toxicities identifies Jak inhibitors effective in mitigating multifaceted toxic responses.
Tao W; Mao X; Davide JP; Ng B; Cai M; Burke PA; Sachs AB; Sepp-Lorenzino L
Mol Ther; 2011 Mar; 19(3):567-75. PubMed ID: 21179008
[TBL] [Abstract][Full Text] [Related]
34. Safety of interleukin-12 gene therapy against cancer: a murine biodistribution and toxicity study.
Imboden M; Shi F; Pugh TD; Freud AG; Thom NJ; Hank JA; Hao Z; Staelin ST; Sondel PM; Mahvi DM
Hum Gene Ther; 2003 Jul; 14(11):1037-48. PubMed ID: 12885344
[TBL] [Abstract][Full Text] [Related]
35. A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis.
Ruiz FE; Clancy JP; Perricone MA; Bebok Z; Hong JS; Cheng SH; Meeker DP; Young KR; Schoumacher RA; Weatherly MR; Wing L; Morris JE; Sindel L; Rosenberg M; van Ginkel FW; McGhee JR; Kelly D; Lyrene RK; Sorscher EJ
Hum Gene Ther; 2001 May; 12(7):751-61. PubMed ID: 11339892
[TBL] [Abstract][Full Text] [Related]
36. Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously.
Dow SW; Fradkin LG; Liggitt DH; Willson AP; Heath TD; Potter TA
J Immunol; 1999 Aug; 163(3):1552-61. PubMed ID: 10415059
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of proinflammatory cytokine production induced by linear and branched polyethylenimine/plasmid DNA complexes in mice.
Kawakami S; Ito Y; Charoensit P; Yamashita F; Hashida M
J Pharmacol Exp Ther; 2006 Jun; 317(3):1382-90. PubMed ID: 16522808
[TBL] [Abstract][Full Text] [Related]
38. Toxicity of cationic lipid-DNA complexes.
Yew NS; Scheule RK
Adv Genet; 2005; 53():189-214. PubMed ID: 16240994
[TBL] [Abstract][Full Text] [Related]
39. Effect of immune response on gene transfer to the lung via systemic administration of cationic lipidic vectors.
Li S; Wu SP; Whitmore M; Loeffert EJ; Wang L; Watkins SC; Pitt BR; Huang L
Am J Physiol; 1999 May; 276(5):L796-804. PubMed ID: 10330036
[TBL] [Abstract][Full Text] [Related]
40. In vitro myotoxicity of selected cationic macromolecules used in non-viral gene delivery.
Brazeau GA; Attia S; Poxon S; Hughes JA
Pharm Res; 1998 May; 15(5):680-4. PubMed ID: 9619774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
